Temaz and Metrogel drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Temaz (temazepam) and Metrogel (metronidazole). Common drug interactions include iron deficiency anaemia among females and abnormal behaviour among males.

The phase IV clinical study analyzes what interactions people have when they take Temaz and Metrogel. It is created by eHealthMe based on reports of 44 people who take the same drugs from the FDA, and is updated regularly.

What is Temaz?

Temaz has active ingredients of temazepam. It is often used in insomnia. eHealthMe is studying from 42,293 Temaz users. Check the latest studies of Temaz.

What is Metrogel?

Metrogel has active ingredients of metronidazole. It is often used in rosacea. eHealthMe is studying from 2,819 Metrogel users. Check the latest studies of Metrogel.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 21, 2026

44 people who take Temaz and Metrogel together, and have interactions are studied.

What are the common drug interactions of Temaz and Metrogel, by gender? *:

female:

Iron deficiency anaemia
Muscular weakness (muscle weakness)
Non-cardiac chest pain
Rash
Abdominal pain lower
Adverse event
Cardiac murmur (an heart sound in valve abnormality)
Crying
Drug exposure during pregnancy
Electrolyte imbalance

male:

Abnormal behaviour
Confusional state
Bone density decreased
Chronic kidney disease
Depression
Emotional distress
Lipids increased (excess lipid in body)
Oedema peripheral (superficial swelling)
Osteopenia (a condition where bone mineral density is lower than normal)
Osteoporosis (bones weak and more likely to break)

What are the common drug interactions of Temaz and Metrogel, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Abdominal discomfort
Adverse event
Anxiety
Cardiac disorder
Depression
Diarrhoea
Drug exposure during pregnancy
Headache (pain in head)
Hyperhidrosis (abnormally increased sweating)
Migraine (headache)

30-39:

n/a

40-49:

Abdominal pain
Back pain
Constipation
Nausea (feeling of having an urge to vomit)
Small intestinal obstruction (blockage in small intestine)

50-59:

Fall
Fatigue (feeling of tiredness)
Abnormal behaviour
Asthma
Drug level decreased
Laceration (tearing of soft body tissue)
Abdominal pain
Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
Constipation
Dyspnoea (difficult or laboured respiration)

60+:

Activities of daily living impaired
Aortic arteriosclerosis (hardening of the aortic arteries)
Dental caries
Dizziness
Duodenal ulcer
Dyskinesia (abnormality or impairment of voluntary movement)
Enterococcus test positive
Epstein-barr virus infection
Extrapyramidal disorder (involuntary muscle spasms in the face and neck)
Family stress

What are the existing conditions these people have? *

Pain: 12 people, 27.27%
Depression: 5 people, 11.36%
Stress And Anxiety: 4 people, 9.09%
Sleep Disorder: 4 people, 9.09%
Hypersensitivity: 4 people, 9.09%
Tuberous Sclerosis (a rare genetic disease that causes benign tumours to grow in the brain and other organs): 3 people, 6.82%
High Blood Pressure: 3 people, 6.82%
High Blood Cholesterol: 3 people, 6.82%

* Approximation only. Some reports may have incomplete information.

Do you take Temaz and Metrogel?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously